SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bill Wexler who wrote (6615)5/10/1999 7:19:00 PM
From: Linda Kaplan  Read Replies (1) of 7041
 
If they could have gotten it approved, they'd have pursued it right now. They are pretending they are waiting for a stronger case for the public! But had it been approved they always could have presented their stronger case to the public whenever they had it ready.

They have avoided commenting on the nitrate studies. While our thread longs have claimed that there are no problems with nitrates, ZONA and SGP have not been willing to make such comments based on their studies. We shorts have felt that there will be as many nitrate problems with Vasomax as Viagra.

ZONA delayed filing for years after their trials were completed, and had plenty of time to create more studies then. Now they are first creating new studies, which they need to get approval!

They withdrew because they would have failed to get approval, and yet they put a weird spin on it about how they will get better PR and sales if they wait. How many people believe it? Is that Researcher guy going to buy new shares now? How about Ron? Where are all those guys anyway?

Covering their margin calls, I guess.

Linda
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext